Is big data too big? Next month, Kristen Mclaughlin and Nitin Gupta will attempt an answer.
The Food and Drug Administration has approved the first nonprescription, “over-the-counter” naloxone nasal spray, Narcan.
Insurtech Oscar Health has named Mark Bertolini as its new chief executive officer, with Bertolini slated to officially take over the role on April 3.
In a lawsuit filed this week, Ohio Attorney General Dave Yost accused pharmacy benefit managers Express Scripts and Prime Therapeutics of using a little-known, Switzerland-based company to illegally drive up drug prices and ultimately push those higher costs onto patients.
CVS Health has announced that it expects to complete its $8 billion acquisition of Signify Health on or around March 29, subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the merger agreement. The companies entered into a definitive agreement in September 2022 under which CVS Health announced it would […]
Ninety four percent of physicians report care delays associated with prior authorization, according to a recent survey released by the American Medical Association. The survey underscores the urgent need for reform and regulation of prior authorization, the AMA said.
In a preview of their HIMSS23 discussion of a coalition aimed at curing healthcare disparities in the city, Russ Hinz of Advocate Health, Stephanie Chia of University of Chicago Medicine and Susan Tolin from Chartis talk about their experiences and the results.
A new bipartisan bill, the Ensuring Patient Access to Critical Breakthrough Products Act, has been introduced by lawmakers looking to require Medicare to cover new breakthrough medical devices for four years.